| Cash Flow | 2025-09-27 | 2025-06-28 |
|---|---|---|
| Net loss | -4,253 | -2,680 |
| Loss on inventory write-down | 823 | - |
| Loss on extinguishment of convertible note payable | -1,335 | -1,335 |
| Depreciation and amortization | 372 | 262 |
| Amortization of operating lease right-of-use assets | 753 | 497 |
| Accretion of original issue discount | -58 | -58 |
| Amortization of debt issuance costs | 139 | 109 |
| Stock-based compensation | 562 | 470 |
| Accounts receivable | 1,181 | 1,186 |
| Receivable from related party | -45 | 450 |
| Inventories | -2,693 | -2,382 |
| Prepaid expenses and other current assets | -302 | -339 |
| Other long-term assets | -198 | -121 |
| Accounts payable | -2,930 | -2,025 |
| Payable to related party | -396 | -174 |
| Accrued compensation | 260 | 189 |
| Accrued expenses | 115 | 107 |
| Deferred revenue | -1,110 | -670 |
| Operating lease liabilities | -825 | -512 |
| Other liabilities | 336 | 282 |
| Net cash used in operating activities | -2,704 | -1,546 |
| Acquisition of property and equipment | 37 | 24 |
| Net cash used in investing activities | -37 | -24 |
| Proceeds from issuance of convertible note payable | 4,000 | 4,000 |
| Cash paid for debt issuance costs | 0 | - |
| Proceeds for stock options exercise | 0 | - |
| Payments on convertible note payable | 3,961 | 3,961 |
| Proceeds from issuance of series b convertible preferred stock | 6,000 | 6,000 |
| Taxes paid related to net share settlements of equity awards | 48 | 14 |
| Net cash provided by financing activities | 5,991 | 6,025 |
| Effect of foreign exchange rate changes | -64 | -64 |
| Net increase (decrease) in cash and cash equivalents | 3,186 | 4,391 |
| Cash and cash equivalents at beginning of period | 2,387 | - |
| Cash and cash equivalents at end of period | 5,573 | - |
IRIDEX CORP (IRIX)
IRIDEX CORP (IRIX)